Medpace
MEDP
216 hedge funds and large institutions have $1.56B invested in Medpace in 2018 Q4 according to their latest regulatory filings, with 50 funds opening new positions, 78 increasing their positions, 69 reducing their positions, and 37 closing their positions.
69% more call options, than puts
Call options by funds: $4.62M | Put options by funds: $2.73M
35% more first-time investments, than exits
New positions opened: 50 | Existing positions closed: 37
14.47% more ownership
Funds ownership: 68.97% → 83.44% (+14%)
13% more repeat investments, than reductions
Existing positions increased: 78 | Existing positions reduced: 69
6% more capital invested
Capital invested by funds: $1.47B → $1.56B (+$85.3M)
4% more funds holding
Funds holding: 207 → 216 (+9)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$103M |
| 2 |
PG
Pendal Group
Sydney,
Australia
|
+$86.6M |
| 3 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$65.6M |
| 4 |
VOYA Investment Management
Atlanta,
Georgia
|
+$28.3M |
| 5 |
Bank of New York Mellon
New York
|
+$23.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LCM
Laurion Capital Management
New York
|
-$57.2M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$34.9M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$16.9M |
| 4 |
Renaissance Technologies
New York
|
-$16.3M |
| 5 |
Two Sigma Investments
New York
|
-$15.6M |
MEDP Hedge Fund Activity: Q4 2018 in Review
216 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Medpace (MEDP) for Q4 2018, worth a combined $1.56B — up 5.8% from $1.47B a quarter earlier.
Buyers outnumbered sellers: 50 funds opened new MEDP positions and 37 closed out — a net gain of 13 holders — while 78 added to existing stakes and 69 trimmed.
The largest buyer was BlackRock, adding an estimated $103M. The largest seller was Laurion Capital Management, cutting an estimated $57.2M.
- 216 institutional investors held Medpace (MEDP) as of Q4 2018, up from 207 in Q3 2018.
- Funds reported $1.56B of Medpace stock for Q4 2018, up 5.8% quarter-over-quarter.
- 50 funds opened new Medpace positions in Q4 2018 and 37 closed out, a net change of +13 holders.
- The largest Medpace buyer in Q4 2018 was BlackRock, an estimated $103M added.
- The largest Medpace seller in Q4 2018 was Laurion Capital Management, an estimated $57.2M sold.
Based on aggregated 13F filings for Q4 2018.